XML 27 R15.htm IDEA: XBRL DOCUMENT v3.24.2
EQUITY
 6 Months Ended
Jun. 30, 2024
Stockholders' Equity Note [Abstract]  
EQUITY EQUITY
The following tables present the changes in consolidated equity (dollars in millions, share amounts in thousands):
Common StockAdditional
Paid-In
Capital		Accumulated
Other
Comprehensive
Loss		Retained Earnings
(Accumulated
Deficit)		Treasury
Stock		Noncontrolling
Interests		Total Equity
Shares
Outstanding		Issued Par
Amount
Balances at December 31, 202399,950 $8 $4,834 $(181)$(192)$(2,861)$1,509 $3,117 
Net income— — — — 2,151 — 82 2,233 
Distributions paid to noncontrolling interests— — — — — — (78)(78)
Other comprehensive income— — — 2 — — — 2 
Sales of businesses and noncontrolling interests, net— — (5)— — — (23)(28)
Repurchases of common stock(2,811)— — — — (280)— (280)
Stock-based compensation expense and issuance of common stock534 — (23)— — — — (23)
Balances at March 31, 202497,673 8 4,806 (179)1,959 (3,141)1,490 4,943 
Net income— — — — 259 — 97 356 
Distributions paid to noncontrolling interests— — — — — — (70)(70)
Other comprehensive income— — — 2 — — — 2 
Purchases of businesses and noncontrolling interests, net— — 12 — — — 64 76 
Repurchases of common stock(1,990)— — — — (273)— (273)
Stock-based compensation expense and issuance of common stock136 — 22 — — — — 22 
Balances at June 30, 202495,819 $8 $4,840 $(177)$2,218 $(3,414)$1,581 $5,056 
Common StockAdditional
Paid-In
Capital		Accumulated
Other
Comprehensive
Loss		Accumulated
Deficit		Treasury
Stock		Noncontrolling
Interests		Total Equity
Shares
Outstanding		Issued Par
Amount
Balances at December 31, 2022102,247 $8 $4,778 $(181)$(803)$(2,660)$1,317 $2,459 
Net income— — — — 143 — 74 217 
Distributions paid to noncontrolling interests— — — — — — (61)(61)
Other comprehensive income— — — 2 — — — 2 
Purchases of businesses and noncontrolling interests, net— — 2 — — — 17 19 
Repurchases of common stock(906)— — — — (50)— (50)
Stock-based compensation expense and issuance of common stock571 — (6)— — — — (6)
Balances at March 31, 2023101,912 8 4,774 (179)(660)(2,710)1,347 2,580 
Net income— — — — 123 — 82 205 
Distributions paid to noncontrolling interests— — — — — — (66)(66)
Other comprehensive income— — — 1 — — — 1 
Purchases of businesses and noncontrolling interests, net— — 4 — — — 18 22 
Repurchases of common stock(580)— — — — (40)— (40)
Stock-based compensation expense and issuance of common stock177 — 22 — — — — 22 
Balances at June 30, 2023101,509 $8 $4,800 $(178)$(537)$(2,750)$1,381 $2,724 
Nonredeemable Noncontrolling Interests
Our nonredeemable noncontrolling interests balances at June 30, 2024 and December 31, 2023 were comprised of $201 million and $185 million, respectively, from our Hospital Operations segment, and $1.380 billion and $1.324 billion, respectively, from our Ambulatory Care segment. Net income amounts available to nonredeemable noncontrolling interests for the six months ended June 30, 2024 and 2023 in the tables above were comprised of $21 million and $14 million, respectively, from our Hospital Operations segment and $158 million and $142 million, respectively, from our Ambulatory Care segment.
Share Repurchase Program
In October 2022, our board of directors authorized the repurchase of up to $1 billion of our common stock through a share repurchase program. Repurchases may be made in open‑market or privately negotiated transactions, at management’s discretion subject to market conditions and other factors, and in a manner consistent with applicable securities laws and regulations. The share repurchase program does not obligate us to acquire any particular amount of common stock, and it may be suspended for periods or discontinued at any time before its scheduled expiration date of December 31, 2024.
The following tables summarize transactions completed under the repurchase program during the periods shown:
PeriodTotal Number of Shares PurchasedAverage Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced ProgramMaximum Dollar Value of Shares That May Yet be Purchased Under the Program
 (In Thousands)(In Thousands)(In Millions)
Six Months Ended June 30, 2024:
January 1 through January 31, 2024—$— —$550 
February 1 through February 29, 2024—$— —$550 
March 1 through March 31, 20242,811$98.86 2,811$272 
April 1 through April 30, 2024—$— —$272 
May 1 through May 31, 2024—$— —$272 
June 1 through June 30, 20241,990$135.85 1,990$2 
January 1 through June 30, 20244,801$114.19 4,801
PeriodTotal Number of Shares PurchasedAverage Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced ProgramMaximum Dollar Value of Shares That May Yet be Purchased Under the Program
 (In Thousands)(In Thousands)(In Millions)
Six Months Ended June 30, 2023:
January 1 through January 31, 2023—$— —$750 
February 1 through February 28, 2023—$— —$750 
March 1 through March 31, 2023906$55.03 906$700 
April 1 through April 30, 2023—$— —$700 
May 1 through May 31, 2023580$69.17 580$660 
June 1 through June 30, 2023—$— —$660 
January 1 through June 30, 20231,486$60.55 1,486